Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.391-393
Main Authors: Bahlis, Nizar Jacques, Tomasson, Michael H., Mohty, Mohamad, Niesvizky, Ruben, Nooka, Ajay K., Manier, Salomon, Maisel, Christopher, Jethava, Yogesh, Martinez-Lopez, Joaquin, Prince, H Miles, Arnulf, Bertrand, Rodriguez Otero, Paula, Koehne, Guenther, Touzeau, Cyrille, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Leip, Eric, Sullivan, Sharon, Conte, Umberto, Viqueira, Andrea, Lesokhin, Alexander M
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1850-6e85178b68fc8de4089abeb1a91315a8b37d69816ebf942a2cbb1f7fd69e4de53
cites
container_end_page 393
container_issue Supplement 1
container_start_page 391
container_title Blood
container_volume 140
creator Bahlis, Nizar Jacques
Tomasson, Michael H.
Mohty, Mohamad
Niesvizky, Ruben
Nooka, Ajay K.
Manier, Salomon
Maisel, Christopher
Jethava, Yogesh
Martinez-Lopez, Joaquin
Prince, H Miles
Arnulf, Bertrand
Rodriguez Otero, Paula
Koehne, Guenther
Touzeau, Cyrille
Raje, Noopur
Iida, Shinsuke
Raab, Marc-Steffen
Leip, Eric
Sullivan, Sharon
Conte, Umberto
Viqueira, Andrea
Lesokhin, Alexander M
description
doi_str_mv 10.1182/blood-2022-162440
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_162440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122017025</els_id><sourcerecordid>S0006497122017025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1850-6e85178b68fc8de4089abeb1a91315a8b37d69816ebf942a2cbb1f7fd69e4de53</originalsourceid><addsrcrecordid>eNp9kc1u1DAQxyMEEkvhAbjNEQ6mtvOxDpy2YVuQugW15RxN7HHXKIlXtrdVnqoPwaGvRbbLmdNII_0_Zn5Z9l7wT0Ioedr13hsmuZRMVLIo-ItsIUqpGOeSv8wWnPOKFfVSvM7exPibc1HkslxkT2trnUY9AY4GbtBSmsBbWPcBR0w4YAduhJ-YHI0pwoNLW7imHneRzOk12YA6-TDBZt8nt-sJNhP1fkC4wj-P9wTJwxlrqO9hg2kfZh8_wmpM7o5G-HDWbFYf2VcXSCcycLulgDtH8fOcEWfHCDb4ARq_9SEBHpql7ZyBdyMlF4eB5XCT9mZ6m72y2Ed692-eZL_O17fNN3b54-J7s7pkWqiSs4pUKZaqq5TVylDBVY0ddQJrkYsSVZcvTVUrUVFn60Ki1F0n7NLOSyoMlflJJo6-OvgYA9l2F9yAYWoFbw8k2mcS7YFEeyQxa74cNTQXu3cU2qjnb2oyz3e3xrv_qP8C71uU3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study</title><source>ScienceDirect®</source><creator>Bahlis, Nizar Jacques ; Tomasson, Michael H. ; Mohty, Mohamad ; Niesvizky, Ruben ; Nooka, Ajay K. ; Manier, Salomon ; Maisel, Christopher ; Jethava, Yogesh ; Martinez-Lopez, Joaquin ; Prince, H Miles ; Arnulf, Bertrand ; Rodriguez Otero, Paula ; Koehne, Guenther ; Touzeau, Cyrille ; Raje, Noopur ; Iida, Shinsuke ; Raab, Marc-Steffen ; Leip, Eric ; Sullivan, Sharon ; Conte, Umberto ; Viqueira, Andrea ; Lesokhin, Alexander M</creator><creatorcontrib>Bahlis, Nizar Jacques ; Tomasson, Michael H. ; Mohty, Mohamad ; Niesvizky, Ruben ; Nooka, Ajay K. ; Manier, Salomon ; Maisel, Christopher ; Jethava, Yogesh ; Martinez-Lopez, Joaquin ; Prince, H Miles ; Arnulf, Bertrand ; Rodriguez Otero, Paula ; Koehne, Guenther ; Touzeau, Cyrille ; Raje, Noopur ; Iida, Shinsuke ; Raab, Marc-Steffen ; Leip, Eric ; Sullivan, Sharon ; Conte, Umberto ; Viqueira, Andrea ; Lesokhin, Alexander M</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-162440</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.391-393</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1850-6e85178b68fc8de4089abeb1a91315a8b37d69816ebf942a2cbb1f7fd69e4de53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497122017025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3535,27903,27904,45759</link.rule.ids></links><search><creatorcontrib>Bahlis, Nizar Jacques</creatorcontrib><creatorcontrib>Tomasson, Michael H.</creatorcontrib><creatorcontrib>Mohty, Mohamad</creatorcontrib><creatorcontrib>Niesvizky, Ruben</creatorcontrib><creatorcontrib>Nooka, Ajay K.</creatorcontrib><creatorcontrib>Manier, Salomon</creatorcontrib><creatorcontrib>Maisel, Christopher</creatorcontrib><creatorcontrib>Jethava, Yogesh</creatorcontrib><creatorcontrib>Martinez-Lopez, Joaquin</creatorcontrib><creatorcontrib>Prince, H Miles</creatorcontrib><creatorcontrib>Arnulf, Bertrand</creatorcontrib><creatorcontrib>Rodriguez Otero, Paula</creatorcontrib><creatorcontrib>Koehne, Guenther</creatorcontrib><creatorcontrib>Touzeau, Cyrille</creatorcontrib><creatorcontrib>Raje, Noopur</creatorcontrib><creatorcontrib>Iida, Shinsuke</creatorcontrib><creatorcontrib>Raab, Marc-Steffen</creatorcontrib><creatorcontrib>Leip, Eric</creatorcontrib><creatorcontrib>Sullivan, Sharon</creatorcontrib><creatorcontrib>Conte, Umberto</creatorcontrib><creatorcontrib>Viqueira, Andrea</creatorcontrib><creatorcontrib>Lesokhin, Alexander M</creatorcontrib><title>Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAQxyMEEkvhAbjNEQ6mtvOxDpy2YVuQugW15RxN7HHXKIlXtrdVnqoPwaGvRbbLmdNII_0_Zn5Z9l7wT0Ioedr13hsmuZRMVLIo-ItsIUqpGOeSv8wWnPOKFfVSvM7exPibc1HkslxkT2trnUY9AY4GbtBSmsBbWPcBR0w4YAduhJ-YHI0pwoNLW7imHneRzOk12YA6-TDBZt8nt-sJNhP1fkC4wj-P9wTJwxlrqO9hg2kfZh8_wmpM7o5G-HDWbFYf2VcXSCcycLulgDtH8fOcEWfHCDb4ARq_9SEBHpql7ZyBdyMlF4eB5XCT9mZ6m72y2Ed692-eZL_O17fNN3b54-J7s7pkWqiSs4pUKZaqq5TVylDBVY0ddQJrkYsSVZcvTVUrUVFn60Ki1F0n7NLOSyoMlflJJo6-OvgYA9l2F9yAYWoFbw8k2mcS7YFEeyQxa74cNTQXu3cU2qjnb2oyz3e3xrv_qP8C71uU3w</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Bahlis, Nizar Jacques</creator><creator>Tomasson, Michael H.</creator><creator>Mohty, Mohamad</creator><creator>Niesvizky, Ruben</creator><creator>Nooka, Ajay K.</creator><creator>Manier, Salomon</creator><creator>Maisel, Christopher</creator><creator>Jethava, Yogesh</creator><creator>Martinez-Lopez, Joaquin</creator><creator>Prince, H Miles</creator><creator>Arnulf, Bertrand</creator><creator>Rodriguez Otero, Paula</creator><creator>Koehne, Guenther</creator><creator>Touzeau, Cyrille</creator><creator>Raje, Noopur</creator><creator>Iida, Shinsuke</creator><creator>Raab, Marc-Steffen</creator><creator>Leip, Eric</creator><creator>Sullivan, Sharon</creator><creator>Conte, Umberto</creator><creator>Viqueira, Andrea</creator><creator>Lesokhin, Alexander M</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study</title><author>Bahlis, Nizar Jacques ; Tomasson, Michael H. ; Mohty, Mohamad ; Niesvizky, Ruben ; Nooka, Ajay K. ; Manier, Salomon ; Maisel, Christopher ; Jethava, Yogesh ; Martinez-Lopez, Joaquin ; Prince, H Miles ; Arnulf, Bertrand ; Rodriguez Otero, Paula ; Koehne, Guenther ; Touzeau, Cyrille ; Raje, Noopur ; Iida, Shinsuke ; Raab, Marc-Steffen ; Leip, Eric ; Sullivan, Sharon ; Conte, Umberto ; Viqueira, Andrea ; Lesokhin, Alexander M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1850-6e85178b68fc8de4089abeb1a91315a8b37d69816ebf942a2cbb1f7fd69e4de53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bahlis, Nizar Jacques</creatorcontrib><creatorcontrib>Tomasson, Michael H.</creatorcontrib><creatorcontrib>Mohty, Mohamad</creatorcontrib><creatorcontrib>Niesvizky, Ruben</creatorcontrib><creatorcontrib>Nooka, Ajay K.</creatorcontrib><creatorcontrib>Manier, Salomon</creatorcontrib><creatorcontrib>Maisel, Christopher</creatorcontrib><creatorcontrib>Jethava, Yogesh</creatorcontrib><creatorcontrib>Martinez-Lopez, Joaquin</creatorcontrib><creatorcontrib>Prince, H Miles</creatorcontrib><creatorcontrib>Arnulf, Bertrand</creatorcontrib><creatorcontrib>Rodriguez Otero, Paula</creatorcontrib><creatorcontrib>Koehne, Guenther</creatorcontrib><creatorcontrib>Touzeau, Cyrille</creatorcontrib><creatorcontrib>Raje, Noopur</creatorcontrib><creatorcontrib>Iida, Shinsuke</creatorcontrib><creatorcontrib>Raab, Marc-Steffen</creatorcontrib><creatorcontrib>Leip, Eric</creatorcontrib><creatorcontrib>Sullivan, Sharon</creatorcontrib><creatorcontrib>Conte, Umberto</creatorcontrib><creatorcontrib>Viqueira, Andrea</creatorcontrib><creatorcontrib>Lesokhin, Alexander M</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bahlis, Nizar Jacques</au><au>Tomasson, Michael H.</au><au>Mohty, Mohamad</au><au>Niesvizky, Ruben</au><au>Nooka, Ajay K.</au><au>Manier, Salomon</au><au>Maisel, Christopher</au><au>Jethava, Yogesh</au><au>Martinez-Lopez, Joaquin</au><au>Prince, H Miles</au><au>Arnulf, Bertrand</au><au>Rodriguez Otero, Paula</au><au>Koehne, Guenther</au><au>Touzeau, Cyrille</au><au>Raje, Noopur</au><au>Iida, Shinsuke</au><au>Raab, Marc-Steffen</au><au>Leip, Eric</au><au>Sullivan, Sharon</au><au>Conte, Umberto</au><au>Viqueira, Andrea</au><au>Lesokhin, Alexander M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>391</spage><epage>393</epage><pages>391-393</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-162440</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.391-393
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_162440
source ScienceDirect®
title Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Safety%20of%20Elranatamab%20in%20Patients%20with%20Relapsed/Refractory%20Multiple%20Myeloma%20Na%C3%AFve%20to%20B-Cell%20Maturation%20Antigen%20(BCMA)-Directed%20Therapies:%20Results%20from%20Cohort%20a%20of%20the%20Magnetismm-3%20Study&rft.jtitle=Blood&rft.au=Bahlis,%20Nizar%20Jacques&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=391&rft.epage=393&rft.pages=391-393&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-162440&rft_dat=%3Celsevier_cross%3ES0006497122017025%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1850-6e85178b68fc8de4089abeb1a91315a8b37d69816ebf942a2cbb1f7fd69e4de53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true